{"path":"Images/Pasted image 20240118232546.png","text":"‘Table 3 Characteristics of AEDs (adapted with permission from Kofke).'” CNS, central nervous system; CYP2B, cytochrome P450 2B; DIC, disseminated intravascular coagulation; ty, elimination half-life; UGT, UDP-glucuronosyltransferase Drug Protein Effects on enzymes ty(h) Elimination Disadvantages and adverse effects binding (%) involved in drug route (%) metabolism Renal Liver Carbamazepine 75 Broad-spectrum inducer 915 1 99 Diplopia, nystagmus, blurred vision, ataxia, dizziness, sedation, hyponatraemia, rash Clonazepam 85 Induce CYP2B family 2060 <5 >90 Sedation Ethosuximide 0 None 3060 <20 <80 Nausea, vomiting, gastrointestinal distress, drowsiness, ataxia Felbamate 25 Mixed inducer and 1322 50 50 Riskof aplastic anaemia and liver toxicity, CNS and inhibitor gastrointestinal side-effects, drug interactions, dizziness, blurred vision, ataxia, weight loss Gabapentin 0 None 57 100 0 Efficacy limited to partial epilepsies, multiple daily dosing, high cost, mild drowsiness, encephalopathy, weight gain, peripheral oedema, weight change Lamotrigine 55 Induces UGTs 1262 10 90 Need for slow titration, hypersensitivity reactions, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis (especially with concurrent valproate), hepatic and renal failure, DIC, arthritis, fever, red cell aplasia, tics, insomnia Levetiracetam <10 None 68 100 0 Iritability, behaviour change, somnolence Oxcarbazepine 40 Mixed inducer and 9 1 99 Interaction with oral contraceptives, hyponatraemia, rash inhibitor ‘Phenobarbitol a5 Broad-spectrum inducer 75-110 25 75 Drowsiness, slurred speech, nystagmus, confusion, somnolence, ataxia, respiratory depression, coma, hypotension, sedation, behaviour disorders Phenytoin % Broad-spectrum inducer 9-36 5 95 Vertigo, ataxia, slurred speech, nystagmus, diplopia, somnolence, stupor, coma, gingival hyperplasia, hirsutism. Hypotension and arrythmias (i.v.) Primadone 0 Broad-spectrum inducer 6-8 100 0 Sedation and dizziness acutely, then similar to phenobarbital Tigabine % None 79 2 98 CNS side-effects, interactions with oral contraceptives, nephrolithiasis, open-angle glaucoma, hypohidrosis, metabolic acidosis, weight loss ‘Topiramate 15 Mixed inducer and 1224 65 35 CNS side-effects, nephrolithiasis, open-angle glaucoma, inhibitor hypohidrosis, metabolic acidosis, weight loss, language dysfunction Valproate % Broad-spectrum 618 2 98 Sedation,gastricdisturbance, weight gain, diarrhoea, tremors, inhibitor ataxia, somnolence, coma, thrombocytopenia, platelet dysfunction, hepatic failure, hair loss, drowsiness Vigabatrin 0 None 57 100 0 Visual field defects, weight gain Zonisamide 40 None 63 35 65 CNS side-effects, allergic reactions, rash, nephrolithiasis, hypohidrosis, irritability, photosensitivity, weight loss","libVersion":"0.3.2","langs":"eng"}